STERIS plc - 8-K Filing
STERIS plc reported fiscal 2026 full-year revenue from continuing operations increased 9% to $5.9 billion, with constant currency organic growth of 7%. As-reported diluted EPS rose to $7.93 (up from $6.16 in FY2025), and adjusted EPS reached $10.17 (from $9.22). The company also announced a new $1 billion share repurchase program. (Items: 2.02 of this Current Report on Form 8-K, including Exhibit 99)
Tickers: $STE